285 related articles for article (PubMed ID: 1422597)
21. Evaluation and interpretation of voltage- and frequency-dependent electrophysiologic effects of a new class I antiarrhythmic agent (nicainoprol) on guinea pig papillary muscle and isolated heart.
Weirich J; Antoni H
J Cardiovasc Pharmacol; 1988 Dec; 12(6):664-71. PubMed ID: 2467084
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres.
Delgado C; Tamargo J; Tejerina T
Br J Pharmacol; 1985 Dec; 86(4):765-75. PubMed ID: 4075015
[TBL] [Abstract][Full Text] [Related]
23. Effects of dimethylpropranolol (UM-272) on the electrophysiological properties of guinea-pig ventricular muscles.
Kodama I; Kondo N; Shibata S; Yamada K
J Pharmacol Exp Ther; 1985 Aug; 234(2):507-14. PubMed ID: 2410595
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiological effects of the combination of imipramine and desipramine in guinea pig papillary muscles.
Delpón E; Valenzuela C; Pérez O; Tamargo J
J Cardiovasc Pharmacol; 1993 Jan; 21(1):13-20. PubMed ID: 7678668
[TBL] [Abstract][Full Text] [Related]
25. Frequency- and voltage-dependent effects of aprindine on the upstroke velocity of action potential in guinea pig ventricular muscles.
Toyama J; Kamiya K; Kodama I; Yamada K
J Cardiovasc Pharmacol; 1987 Feb; 9(2):165-72. PubMed ID: 2435994
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological effects of Ro 22-9194, a new antiarrhythmic agent, on guinea-pig ventricular cells.
Maruyama K; Kodama I; Anno T; Suzuki R; Toyama J
Br J Pharmacol; 1995 Jan; 114(1):19-26. PubMed ID: 7712017
[TBL] [Abstract][Full Text] [Related]
27. Frequency- and voltage-dependent effects of recainam on the upstroke velocity of action potential in rabbit ventricular muscle.
Kamiya K; Takikawa R; Singh BN
J Cardiovasc Pharmacol; 1989 Apr; 13(4):630-7. PubMed ID: 2471002
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiologic effects of TYB-3823, a new antiarrhythmic agent, on isolated guinea pig ventricular muscles.
Kodama I; Morimoto M; Toyama J; Shibata S
J Cardiovasc Pharmacol; 1989 Apr; 13(4):616-23. PubMed ID: 2471000
[TBL] [Abstract][Full Text] [Related]
29. Modelling frequency- and voltage-dependent effects of a class I antiarrhythmic drug (nicainoprol) on Vmax of the cardiac action potential from guinea-pig papillary muscle.
Weirich J; Antoni H
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):456-64. PubMed ID: 2586635
[TBL] [Abstract][Full Text] [Related]
30. Effects of RS-2135, a new antiarrhythmic agent, on the kinetics of use-dependent decrease in maximum upstroke velocity in guinea pig ventricular myocardium.
Yorikane R; Sada T; Koike H
J Cardiovasc Pharmacol; 1993 Mar; 21(3):430-4. PubMed ID: 7681504
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles.
Tamargo J; Tejerina T; Delgado C; Barrigon S
Eur J Pharmacol; 1985 Feb; 109(2):219-27. PubMed ID: 3996472
[TBL] [Abstract][Full Text] [Related]
32. Electrophysiological effects of KT-362, a new antiarrhythmic agent with vasodilating action, on isolated guinea pig ventricular muscle.
Kodama I; Wakabayashi S; Toyama J; Shibata S; Yamada K
J Cardiovasc Pharmacol; 1988 Jun; 11(6):687-93. PubMed ID: 2457764
[TBL] [Abstract][Full Text] [Related]
33. [Frequency- and voltage-dependent effects of changrolin on maximal upstroke velocity of action potentials in guinea pig papillary muscles].
Pan H; Shen WQ; Yu ZM; Xu B
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):317-21. PubMed ID: 2104485
[TBL] [Abstract][Full Text] [Related]
34. Membrane potential-dependent effects of SC-36602, a new class I antiarrhythmic agent on cardiac action potentials.
Borowicz LE; Schniepp HC; Sanguinetti MC
J Cardiovasc Pharmacol; 1987 Jan; 9(1):57-64. PubMed ID: 2434795
[TBL] [Abstract][Full Text] [Related]
35. Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium.
Hasegawa J; Hirai S; Noguchi N; Hisatome I; Kotake H; Mashiba H
Br J Pharmacol; 1990 Apr; 99(4):815-9. PubMed ID: 2361175
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological profile of the antiarrhythmic compound asocainol studied on perfused guinea-pig hearts and on isolated cardiac preparations.
Langenfeld H; Haverkampf K; Antoni H
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):155-62. PubMed ID: 6472493
[TBL] [Abstract][Full Text] [Related]
37. Inotropic and electrophysiological effects of PY 108-068 on isolated cardiac preparations.
Tejerina MT; Delgado C; Diez J; Tamargo J
Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):64-80. PubMed ID: 6497511
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated guinea pig papillary muscle.
Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Szénási G; Varró A; Nánási PP
Gen Pharmacol; 1997 Aug; 29(2):275-80. PubMed ID: 9251913
[TBL] [Abstract][Full Text] [Related]
39. Cellular electrophysiological properties of a new aminosteroid antiarrhythmic agent, SC-35135.
Borowicz LE; Martin CL; Sanguinetti MC
J Cardiovasc Pharmacol; 1988 Aug; 12(2):218-26. PubMed ID: 2459553
[TBL] [Abstract][Full Text] [Related]
40. Effects of AFD-21, a new class I antiarrhythmic agent, and AFD-19, its active metabolite, on the maximal rate of rise of action potentials in guinea pig papillary muscles: dependence on time, voltage, and action potential duration.
Kojima M; Ban T
J Cardiovasc Pharmacol; 1989 Mar; 13(3):483-93. PubMed ID: 2471896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
